These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 10022531)

  • 21. Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system.
    Chavez CL; Keravala A; Chu JN; Farruggio AP; Cuéllar VE; Voorberg J; Calos MP
    Hum Gene Ther; 2012 Apr; 23(4):390-8. PubMed ID: 22077817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual vectors expressing murine factor VIII result in sustained correction of hemophilia A mice.
    Mah C; Sarkar R; Zolotukhin I; Schleissing M; Xiao X; Kazazian HH; Byrne BJ
    Hum Gene Ther; 2003 Jan; 14(2):143-52. PubMed ID: 12614565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naked DNA transfer of Factor VIII induced transgene-specific, species-independent immune response in hemophilia A mice.
    Ye P; Thompson AR; Sarkar R; Shen Z; Lillicrap DP; Kaufman RJ; Ochs HD; Rawlings DJ; Miao CH
    Mol Ther; 2004 Jul; 10(1):117-26. PubMed ID: 15233948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interindividual variability in transgene mRNA and protein production following adeno-associated virus gene therapy for hemophilia A.
    Fong S; Yates B; Sihn CR; Mattis AN; Mitchell N; Liu S; Russell CB; Kim B; Lawal A; Rangarajan S; Lester W; Bunting S; Pierce GF; Pasi KJ; Wong WY
    Nat Med; 2022 Apr; 28(4):789-797. PubMed ID: 35411075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A.
    Evans GL; Morgan RA
    Proc Natl Acad Sci U S A; 1998 May; 95(10):5734-9. PubMed ID: 9576953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
    Rangarajan S; Walsh L; Lester W; Perry D; Madan B; Laffan M; Yu H; Vettermann C; Pierce GF; Wong WY; Pasi KJ
    N Engl J Med; 2017 Dec; 377(26):2519-2530. PubMed ID: 29224506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Non-viral vector mediating human coagulation factor VIII gene expression in mouse 32D cell line].
    Yin J; Wang HL; Wang XF; Qu B; Wu WM; Ding QL; Fu QH; Qi ZW; Wang ZY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):721-5. PubMed ID: 15631647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of human coagulation factor VIII in adipocytes transduced with the simian immunodeficiency virus agmTYO1-based vector for hemophilia A gene therapy.
    Ogata K; Mimuro J; Kikuchi J; Tabata T; Ueda Y; Naito M; Madoiwa S; Takano K; Hasegawa M; Ozawa K; Sakata Y
    Gene Ther; 2004 Feb; 11(3):253-9. PubMed ID: 14737084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the biological differences of canine and human factor VIII in gene delivery: implications in human hemophilia treatment.
    Wang Q; Dong B; Firrman J; Wu W; Roberts S; Moore AR; Liu LS; Chin MP; Diao Y; Kost J; Xiao W
    Gene Ther; 2016 Jul; 23(7):597-605. PubMed ID: 27064790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of testes and semen from rabbits treated by intravenous injection with a retroviral vector encoding the human factor VIII gene: no evidence of germ line transduction.
    Roehl HH; Leibbrandt ME; Greengard JS; Kamantigue E; Glass WG; Giedlin M; Boekelheide K; Johnson DE; Jolly DJ; Sajjadi NC
    Hum Gene Ther; 2000 Dec; 11(18):2529-40. PubMed ID: 11119423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro expression of human factor VIII gene induced by sodium butyrate].
    Yin J; Wang H; Wang X; Chu H; Li D; Chen H; Fu Q; Duan B; Kang W; Ding Q; Qi Z; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):463-5. PubMed ID: 12482356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase 1 trial of FVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion.
    Powell JS; Ragni MV; White GC; Lusher JM; Hillman-Wiseman C; Moon TE; Cole V; Ramanathan-Girish S; Roehl H; Sajjadi N; Jolly DJ; Hurst D
    Blood; 2003 Sep; 102(6):2038-45. PubMed ID: 12763932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic modification of bone-marrow mesenchymal stem cells and hematopoietic cells with human coagulation factor IX-expressing plasmids.
    Sam MR; Azadbakhsh AS; Farokhi F; Rezazadeh K; Sam S; Zomorodipour A; Haddad-Mashadrizeh A; Delirezh N; Mokarizadeh A
    Biologicals; 2016 May; 44(3):170-7. PubMed ID: 26928674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiyear therapeutic benefit of AAV serotypes 2, 6, and 8 delivering factor VIII to hemophilia A mice and dogs.
    Jiang H; Lillicrap D; Patarroyo-White S; Liu T; Qian X; Scallan CD; Powell S; Keller T; McMurray M; Labelle A; Nagy D; Vargas JA; Zhou S; Couto LB; Pierce GF
    Blood; 2006 Jul; 108(1):107-15. PubMed ID: 16522813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retroviral modification of mesenchymal stem cells for gene therapy of hemophilia.
    Doering CB
    Methods Mol Biol; 2008; 433():203-12. PubMed ID: 18679625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction.
    Tiede A; Eder M; von Depka M; Battmer K; Luther S; Kiem HP; Ganser A; Scherr M
    Gene Ther; 2003 Oct; 10(22):1917-25. PubMed ID: 14502221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the activity levels of rat FVIII and human FVIII delivered by adeno-associated viral vectors both in vitro and in vivo.
    Zhang W; Mao J; Shen Y; Zhang G; Shao Y; Ruan Z; Wang Y; Wu W; Wang X; Zhu J; Chen S; Xiao W; Xi X
    Blood Cells Mol Dis; 2018 Nov; 73():47-54. PubMed ID: 30249384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector.
    Balagué C; Zhou J; Dai Y; Alemany R; Josephs SF; Andreason G; Hariharan M; Sethi E; Prokopenko E; Jan HY; Lou YC; Hubert-Leslie D; Ruiz L; Zhang WW
    Blood; 2000 Feb; 95(3):820-8. PubMed ID: 10648392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexpression of factor VIII heavy and light chain adeno-associated viral vectors produces biologically active protein.
    Burton M; Nakai H; Colosi P; Cunningham J; Mitchell R; Couto L
    Proc Natl Acad Sci U S A; 1999 Oct; 96(22):12725-30. PubMed ID: 10535990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor IX model.
    Krebsbach PH; Zhang K; Malik AK; Kurachi K
    J Gene Med; 2003 Jan; 5(1):11-7. PubMed ID: 12516047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.